Health Condition 1: null- Piles ( Haemorrhoids)
Conditions
Interventions
Intervention1: 1-Pranada Gutika
2-Abhayarishta: Pranada Gutika - 500 mg tds, orally, after food with lukewarm water for 28 days Abhayarishta- 20 ml BD, orally, after food with lukewarm water for 28 d
Sponsors
CCRAS
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex aged 16 â??60 years. 2. Presence of 1st, 2nd& 3rd degree Arsha (Hemorrhoids) confirmed by clinical /proctoscopic / colonoscopic examination (With or without bleeding / painful or painless). 3.Willing and able to participate in the study for 06 weeks
Exclusion criteria
Exclusion criteria: 1.Thrombosed&Strangulated pile mass (Hemorrhoids) 2.Bleeding diathesis 3.Cirrhosis of Liver- Portal hypertension 4.Ulcerative colitis / Crohnâ??s disease 5.Patients with evidence of malignancy 6.Patients on prolonged ( > 6 weeks) medication with corticosteoids, antidepressants, anticholinergics, immunosuppressants, estrogen replacement therapy etc. or any other drugs that may have an influence on the outcome of the study. 7. Patients suffering from major systemic illness necessitating long term drug etc. 8.Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months. 9. Patients having uncontrolled Diabetes Mellitus (Blood Sugar Fasting > 120mg/dl). 10. Pregnant/ lactating females. 11. Patients on oral contraceptives. 12. History of hypersensitivity to any of the trial drugs or their ingredients. 13. Patients who have completed participation in any other clinical trial during the past six (06) months. 14. Any other condition which the Investigator thinks may jeopardize the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the pile mass evident by inspection / proctoscopy (visualperception by physician and photography)Timepoint: Reduction in the pile mass evident by inspection / proctoscopy (visualperception by physician and photography) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Control of bleeding as assessed by physician. 2.Relief from constipation (subjective through interrogation) 3.Improvement in Quality of Life as assessed by SF-36 ( At baseline, after 28 days and after 42 days ) Timepoint: Time points- Before Treatment and After Treatment Time points- Before Treatment ( At baseline) and After Treatment ( after 28 days) | — |
Countries
India
Contacts
Public ContactDr RG Reddy
R. R. A. Podar Ayurveda Cancer Research Institute (CCRAS)
Outcome results
None listed